High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$585
$585
Total Sells (Filtered)
$665K
$665,664
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
BIIB
P
BIOGEN INC.
Murphy Nicole
• Officer • Head of Pharm Ops and Tech
Discretionary Buy
2026-02-12
$585
|
||||||
| BIIB |
BIOGEN INC.
|
Officer • Head of Pharm Ops and Tech
Discretionary Buy
|
2026-02-12 | $585 | P | Form 4 |
|
BIIB
S
BIOGEN INC.
Singhal Priya
• Officer • Head of Development
10b5-1 SellΔOwn -24.9%
2026-02-09
$531,548
|
||||||
| BIIB |
BIOGEN INC.
|
Officer • Head of Development
10b5-1 SellΔOwn -24.9%
|
2026-02-09 | $531,548 | S | Form 4 |
|
BIIB
S
BIOGEN INC.
Singhal Priya
• Officer • Head of Development
10b5-1 SellΔOwn -10.7%
2026-02-02
$134,116
|
||||||
| BIIB |
BIOGEN INC.
|
Officer • Head of Development
10b5-1 SellΔOwn -10.7%
|
2026-02-02 | $134,116 | S | Form 4 |
| BIIB |
BIOGEN INC.
|
CEO
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |